The Effects of Pharyngeal Packing on the Postoperative Gastric Fluid Volume in Patients Undergoing Functional Endoscopic Nasal Surgery
Launched by KASR EL AINI HOSPITAL · Apr 26, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a procedure called pharyngeal packing affects the amount of fluid in the stomach after surgery. The research focuses on patients who are scheduled to have a type of nasal surgery known as Functional Endoscopic Sinus Surgery (FESS). By using ultrasound, the doctors will assess how this packing technique influences gastric fluid volume during and after the operation.
To be eligible for this trial, participants need to be adults over 18 years old who are in good health (classified as physical status I-II by the American Society of Anesthesiologists) and are having elective FESS under general anesthesia. However, individuals who have certain health conditions that increase the risk of aspiration (like severe acid reflux), are pregnant, have a high body weight (BMI over 35), or choose not to participate will not be included. If you join the study, you can expect to undergo standard procedures along with the additional monitoring related to the pharyngeal packing technique. This research aims to improve patient safety and outcomes during nasal surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants will be adult patients (above 18 years), with American Society of Anesthesiologists physical status I-II, scheduled for elective FESS under general anesthesia.
- Exclusion Criteria:
- • Patients at risk of aspiration (patients with lower esophageal disease such as Hiatus hernia, or GERD and DM).
- • Pregnancy.
- • Body mass index (BMI) greater than 35 kg/m2.
- • Refusal of the patient.
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Khaled Sarhan, MD
Principal Investigator
Cairo University Hospitals
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported